WOODLEA HOUSE SURGERY — All Prescriptions & Medications — Page 10
Practice Code: J81633 | BOURNEMOUTH, BH8 9NX
Showing results 451-500 of 539
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Timolol and travoprost | 16 | 48 | £204 | -50.5% ▼ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 16 | 16 | £225 | -85.9% ▼ |
| 16 | 191 | £1.4K | +13.6% ▲ | |
| 16 | 42 | £326 | -55.2% ▼ | |
| 16 | 300 | £1.0K | +109.3% ▲ | |
| Indacaterol maleate | 15 | 570 | £581 | +72.8% ▲ |
| Levomepromazine hydrochloride | 15 | 116 | £223 | -34.8% ▼ |
| Nortriptyline | 15 | 798 | £18 | -89.7% ▼ |
| Alfuzosin hydrochloride | 15 | 630 | £148 | -79.0% ▼ |
| Mercaptopurine | 15 | 399 | £174 | -3.1% ▼ |
| Prednisolone sodium phosphate | 15 | 560 | £361 | +17.6% ▲ |
| Olopatadine | 15 | 80 | £71 | -65.8% ▼ |
| 15 | 310 | £168 | -80.6% ▼ | |
| 15 | 720 | £2.8K | -32.8% ▼ | |
| 15 | 305 | £1.1K | -7.4% ▼ | |
| Celiprolol hydrochloride | 14 | 392 | £419 | +5.9% ▲ |
| Hydroxyzine hydrochloride | 14 | 1,092 | £27 | -73.7% ▼ |
| Citalopram hydrochloride | 14 | 210 | £145 | -12.8% ▼ |
| Ethosuximide | 14 | 6,616 | £8.2K | -5.1% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 14 | 3,400 | £172 | -90.7% ▼ |
| Leuprorelin acetate | 14 | 14 | £3.1K | -69.8% ▼ |
| Azelaic acid | 14 | 420 | £94 | -41.4% ▼ |
| 14 | 95 | £262 | +93.2% ▲ | |
| 14 | 750 | £1.3K | +73.2% ▲ | |
| 14 | 420 | £230 | +171.2% ▲ | |
| 14 | 750 | £156 | +39.4% ▲ | |
| 14 | 1,560 | £4.9K | +18.9% ▲ | |
| 14 | 210 | £907 | +74.8% ▲ | |
| Fluvastatin sodium | 13 | 364 | £51 | -43.8% ▼ |
| Mometasone/glycopyrronium/indacaterol | 13 | 390 | £550 | -14.2% ▼ |
| Metformin hydrochloride/sitagliptin | 13 | 1,120 | £205 | -65.3% ▼ |
| Alogliptin/metformin | 13 | 728 | £329 | -68.8% ▼ |
| Empagliflozin/linagliptin | 13 | 364 | £690 | +0.3% vs avg |
| Brimonidine tartrate | 13 | 65 | £85 | -67.4% ▼ |
| Travoprost | 13 | 85 | £55 | -72.4% ▼ |
| Hydrocortisone acetate | 13 | 450 | £86 | -80.3% ▼ |
| Gamolenic acid | 13 | 1,092 | £265 | +25.9% ▲ |
| Heparinoid | 13 | 650 | £49 | -0.3% vs avg |
| 13 | 205 | £1.3K | -36.6% ▼ | |
| 13 | 390 | £711 | +56.7% ▲ | |
| 13 | 1,020 | £750 | -2.1% ▼ | |
| 13 | 490 | £813 | +48.4% ▲ | |
| Nizatidine | 12 | 690 | £333 | -65.1% ▼ |
| Lofepramine hydrochloride | 12 | 448 | £194 | -59.9% ▼ |
| Hyoscine hydrobromide | 12 | 1,008 | £165 | -64.9% ▼ |
| Perampanel | 12 | 336 | £1.6K | -44.6% ▼ |
| Phenobarbital | 12 | 336 | £59 | -61.0% ▼ |
| Ofloxacin | 12 | 336 | £399 | +46.0% ▲ |
| Biphasic insulin lispro | 12 | 240 | £1.5K | -72.0% ▼ |
| Alogliptin | 12 | 504 | £455 | -95.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.